SOC Telemed (SOC Telemed) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Dec. 2021)

View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

SOC Telemed's net issuance of preferred for the six months ended in Dec. 2021 was $0.00 Mil. The number is 0, which means that SOC Telemed has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

SOC Telemed's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2021 was $0.00 Mil.

SOC Telemed Net Issuance of Preferred Stock Historical Data

The historical data trend for SOC Telemed's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOC Telemed Net Issuance of Preferred Stock Chart

SOC Telemed Annual Data

Trend

Dec19

Dec20

Dec21

Net Issuance of Preferred Stock

3.80

-52.24

SOC Telemed Semi-Annual Data
	Dec19	Dec20	Dec21
Net Issuance of Preferred Stock	3.80	-52.24	-

SOC Telemed Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2021 was $0.00 Mil.

SOC Telemed Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of SOC Telemed's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

SOC Telemed (SOC Telemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMDW) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190

Website

https://www.soctelemed.com

SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.

Executives

David R. Fletcher	officer: Interim CFO	C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula	officer: Chief Operating Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman	director	1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb	officer: Chief Financial Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p.	director, 10 percent owner	450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge	director	C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co.	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol	director	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee	officer: Chief Technology Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
John W. Kalix	director, officer: Chief Executive Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190